Company intelligence / Profile preview

VetSynova

Thailand

Ownership: Private
Development stage: Other

Overview

VetSynova develops and commercializes a portfolio of pet health products, including antimicrobial wound care solutions, skin and ear care, and nutritional supplements. Their products are veterinarian-developed and target common pet health issues such as wound healing, skin conditions, and general wellness. Key to their wound care line is Microcyn Technology, a hospital-grade antimicrobial system that is claimed to kill germs within 30 seconds and is marketed as being as safe as water.

Therapeutic areas: ImmunologyOtherDermatology
Modalities: DeviceSmall moleculeSupplement
Industry: Veterinary

Partnerships

Microcyn Technology (patented technology used in wound care products)Dermodacyn (distribution partner in specific Asian markets)

Beyond the preview

Go deeper on VetSynova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VetSynova.

Explore the full profile